Building Biological Tool-Use Agents: Architecture and Patterns

The vision of agentic omics — autonomous AI systems that orchestrate biological discovery — depends on a deceptively simple capability: tool use. An agent that can reason about biology but cannot access BLAST, AlphaFold, or single-cell analysis pipelines is like a biologist who understands theory but has never touched a pipette.

This post provides a practical architecture for building biological tool-use agents. We cover the essential tool inventory, the unique error-handling challenges of biological data, prompt engineering patterns for biological reasoning, and a reference architecture based on the ReAct (Reason + Act) loop. This is the “how-to” companion to Post 13’s conceptual overview and Post 14’s vision of agentic omics.

The Core Architecture: ReAct Meets Biology

The ReAct pattern — interleaving reasoning traces with actionable tool calls — has emerged as the dominant architecture for agentic systems. For biological applications, the pattern looks like this:

Observation: User asks "What's the structural impact of the BRCA1 R1699Q variant?"
Thought: I need to (1) get the protein sequence, (2) predict wild-type structure, 
         (3) predict mutant structure, (4) compare them, (5) check literature for known effects
Action: Query UniProt for BRCA1 sequence
Observation: Retrieved sequence: MSK... (1863 amino acids)
Thought: Now I need to predict structure. AlphaFold 3 is best for this, but I should 
         also run ESM-3 for comparison since it doesn't require MSA.
Action: Call AlphaFold3Server with sequence + R1699Q mutation
Observation: Structure predicted. pLDDT = 92 for wild-type, 87 for mutant. 
         R1699Q shows local destabilization in BRCT domain.
Thought: The pLDDT drop suggests structural impact. Let me check if this variant 
         is in ClinVar and what's known clinically.
Action: Query ClinVar API for BRCA1 R1699Q
Observation: ClinVar: Pathogenic (5 submissions), associated with breast cancer risk.
Thought: I have enough information. The variant causes local structural destabilization 
         in the BRCT domain and is clinically classified as pathogenic.
Final Answer: The BRCA1 R1699Q variant...

This loop — Thought → Action → Observation → Thought — is the engine of biological agency. But biological tool use has unique challenges that generic ReAct implementations don’t address.

The Biological Tool Inventory

A competent biological agent needs access to tools spanning sequence analysis, structure prediction, expression analysis, pathway knowledge, and literature. Here’s the essential inventory, organized by function:

Sequence Analysis Tools

Practical note: For production agents, cache BLAST results and MSA computations. Homology searches are expensive and frequently repeated.

Structure Prediction and Analysis

Critical limitation: AlphaFold 3’s accuracy for protein-ligand interactions remains contested. A 2025 benchmark in Nature Methods found AF3’s ligand docking RMSD averaged 2.8Å — usable for screening but not for lead optimization without experimental validation.

Expression and Single-Cell Analysis

Pathway and Network Analysis

Literature and Knowledge Retrieval

Chemical and Drug Discovery

Handling Biological Tool Failures

Biological tools fail differently than software APIs. A BLAST search doesn’t return a 404 — it returns no significant hits. An AlphaFold prediction doesn’t crash — it returns a structure with low confidence. Agents must handle these “soft failures” gracefully.

Confidence-Aware Reasoning

Every biological prediction comes with uncertainty. Agents must propagate confidence scores through their reasoning:

# Pseudocode for confidence-aware tool use
result = alphafold.predict(sequence)
if result.pLDDT < 70:
    agent.thought("Low confidence prediction (pLDDT={}). Should note uncertainty.".format(result.pLDDT))
    agent.final_answer(include_uncertainty=True)
elif result.pLDDT < 90:
    agent.thought("Moderate confidence. Structure likely correct at domain level but loop regions uncertain.")
else:
    agent.thought("High confidence prediction. Can use for downstream analysis.")

Key thresholds from CASP15/16:

• pLDDT > 90: High confidence (atomic-level accuracy)
• pLDDT 70-90: Confident at domain level
• pLDDT 50-70: Low confidence (use with caution)
• pLDDT < 50: Very low confidence (likely disordered)

Partial Results and Contradictory Evidence

Biological tools often return partial or contradictory results. Consider this scenario:

Agent query: "Is TP53 R248Q pathogenic?"

Tool results:
- ClinVar: Pathogenic (47 submissions)
- PolyPhen-2: Probably damaging (score 0.998)
- SIFT: Deleterious (score 0.00)
- AlphaFold 3: Local destabilization at mutation site
- Literature search: 2,341 papers mention this variant

But:
- Some functional assays show retained transactivation activity
- Population frequency in gnomAD: 0.0001 (very rare but present)

The agent must synthesize this into a nuanced answer:

“TP53 R248Q is classified as pathogenic in ClinVar with strong consensus (47 submissions). Computational predictors (PolyPhen-2, SIFT) and structural analysis (AlphaFold 3) support pathogenicity through loss of DNA contact and local destabilization. However, some functional assays suggest partial retained activity, and the variant appears at very low frequency in gnomAD, suggesting it may have incomplete penetrance or context-dependent effects. Clinical interpretation should consider family history and co-occurring variants.”

This is biological reasoning — not just reporting tool outputs, but integrating them with appropriate caveats.

Timeout and Rate Limit Handling

Many biological APIs have strict rate limits:

• NCBI E-utilities: 3 requests/second without API key, 10/second with key
• EMBL-EBI: Varies by service; some require job submission + polling
• AlphaFold server: Queue-based; predictions can take hours for large proteins

Agents must implement:

1. Request queuing — batch requests when possible
2. Exponential backoff — respect rate limits gracefully
3. Alternative tool fallbacks — if AlphaFold server is down, try ESMFold
4. Progress reporting — for long-running jobs, report status to user

Prompt Engineering for Biological Agents

The system prompt shapes how the agent reasons about biology. Here’s a reference template:

You are a biological research assistant with access to computational tools for 
sequence analysis, structure prediction, expression analysis, and literature search.

Your role is to help researchers answer biological questions by:
1. Breaking complex questions into tractable sub-questions
2. Selecting appropriate tools for each sub-question
3. Interpreting tool outputs with appropriate uncertainty
4. Synthesizing results into coherent, evidence-based answers

Guidelines:
- Always cite specific databases, tools, and papers when making claims
- Report confidence scores (pLDDT, E-values, p-values) when available
- Distinguish between computational predictions and experimental evidence
- Acknowledge limitations — no tool is perfect
- For clinical questions, emphasize that computational predictions are not 
  diagnostic and require clinical validation
- When uncertain, say so. Do not hallucinate biological facts.

Available tools:
[Tool descriptions with usage examples]

Example reasoning trace:
[Show a complete ReAct loop for a representative question]

Few-Shot Examples for Biological Reasoning

Include worked examples in the prompt to demonstrate the expected reasoning style:

Example 1: Variant Interpretation

User: "What's the impact of the EGFR L858R mutation?"

Thought: This is a well-studied oncogenic mutation in lung cancer. I should:
(1) Confirm the variant exists in ClinVar
(2) Check structural impact with AlphaFold
(3) Search literature for functional studies and clinical significance
(4) Note any approved therapies targeting this mutation

Action: Query ClinVar for EGFR L858R
Observation: ClinVar: Pathogenic (89 submissions), associated with lung adenocarcinoma

Action: Query AlphaFold 3 for EGFR structure with L858R mutation
Observation: L858R is in the kinase domain. Mutation stabilizes active conformation.

Action: Search PubMed for "EGFR L858R tyrosine kinase inhibitor"
Observation: 1,200+ papers. L858R sensitizes to gefitinib and erlotinib (first-gen TKIs).

Final Answer: EGFR L858R is a pathogenic, oncogenic mutation in the kinase domain 
that stabilizes the active conformation. It's found in ~15% of lung adenocarcinomas 
and confers sensitivity to EGFR tyrosine kinase inhibitors (gefitinib, erlotinib). 
This is one of the best-characterized driver mutations in cancer, with extensive 
clinical validation and FDA-approved targeted therapies.

Domain-Specific Constraints

Add constraints specific to biological reasoning:

Constraints:
- Never claim a variant is "definitely pathogenic" without clinical evidence
- Distinguish between "predicted to be damaging" (computational) and 
  "experimentally validated" (functional assays)
- For drug-target interactions, specify whether evidence is computational 
  (docking), in vitro (binding assays), in vivo (animal models), or clinical
- Population genetics claims must reference specific databases (gnomAD, 1000 Genomes)
  and specify ancestry groups when relevant

Reference Architecture: Building the Agent

Here’s a reference architecture for a biological tool-use agent using LangGraph:

from langgraph.graph import StateGraph, END
from typing import TypedDict, Annotated, List
import operator

class AgentState(TypedDict):
    messages: Annotated[List[dict], operator.add]
    tool_outputs: Annotated[List[dict], operator.add]
    reasoning_trace: Annotated[List[str], operator.add]
    confidence_scores: Annotated[dict, operator.add]
    final_answer: str

# Define nodes
def reasoner(state: AgentState):
    """LLM node that generates thoughts and selects tools"""
    # Prompt includes system instructions + conversation history + tool descriptions
    response = llm.invoke(state["messages"] + system_prompt)
    # Parse response for thought + action selection
    return {"reasoning_trace": [response.thought], "messages": [response]}

def tool_executor(state: AgentState):
    """Executes selected biological tools"""
    tool_name = state["messages"][-1]["tool_choice"]
    tool_params = state["messages"][-1]["tool_params"]
    
    if tool_name == "blast":
        result = run_blast(tool_params["sequence"], tool_params["database"])
    elif tool_name == "alphafold":
        result = run_alphafold(tool_params["sequence"])
    elif tool_name == "clinvar":
        result = query_clinvar(tool_params["variant"])
    # ... other tools
    
    return {"tool_outputs": [result], "confidence_scores": {tool_name: result.confidence}}

def synthesizer(state: AgentState):
    """Synthesizes tool outputs into final answer"""
    # Check if we have enough information
    if len(state["tool_outputs"]) < min_required_tools:
        return {"messages": [{"role": "assistant", "content": "Need more data..."}]}
    
    # Generate final answer with citations
    answer = llm.invoke(build_synthesis_prompt(state))
    return {"final_answer": answer}

# Build graph
workflow = StateGraph(AgentState)
workflow.add_node("reasoner", reasoner)
workflow.add_node("tool_executor", tool_executor)
workflow.add_node("synthesizer", synthesizer)

workflow.set_entry_point("reasoner")
workflow.add_edge("reasoner", "tool_executor")
workflow.add_edge("tool_executor", "synthesizer")
workflow.add_edge("synthesizer", END)

agent = workflow.compile()

Memory and Provenance

Biological agents must track:

1. Tool call provenance — which tool produced which result, with what parameters
2. Version tracking — AlphaFold 2 vs. 3, GRCh37 vs. GRCh38 genome builds
3. Temporal context — when was this analysis run? (databases update)

Example memory structure:

{
  "session_id": "bio-agent-20260311-001",
  "query": "BRCA1 R1699Q structural impact",
  "tool_calls": [
    {
      "tool": "uniprot",
      "params": {"accession": "P38398"},
      "timestamp": "2026-03-11T09:45:22Z",
      "result_hash": "sha256:abc123..."
    },
    {
      "tool": "alphafold3",
      "params": {"sequence": "MSK...", "mutation": "R1699Q"},
      "timestamp": "2026-03-11T09:47:15Z",
      "result_hash": "sha256:def456...",
      "confidence": {"pLDDT": 87}
    }
  ],
  "genome_build": "GRCh38",
  "database_versions": {
    "clinvar": "2026-02-28",
    "uniprot": "2026-03-01"
  }
}

This enables reproducibility: six months later, you can re-run the analysis and see if database updates changed the conclusion.

Open-Source Implementations

Several open-source projects demonstrate biological agent architectures:

BioAgents (Scientific Reports, 2025)

A multi-agent system for bioinformatics analysis published in Scientific Reports (November 2025). Key features:

• Specialized agents for genomics, proteomics, and pathway analysis
• Consensus mechanism for conflicting predictions
• Integration with BLAST, AlphaFold, and KEGG
• Limitation: Focused on batch analysis rather than interactive querying

The Virtual Lab (bioRxiv, 2024)

A modular agent architecture for antibody design with experimental validation:

• Assigns tasks to different agents (design, validation, optimization)
• Tools include ESM, AlphaFold-Multimer, and Rosetta
• Notable: Actually validated predictions experimentally — designed nanobodies showed binding in vitro
• Limitation: Narrow scope (antibodies only)

ChemCrow (Nature Machine Intelligence, 2024)

While focused on chemistry rather than biology, ChemCrow’s architecture is highly relevant:

• 13 tools for organic synthesis (reaction prediction, retrosynthesis, property calculation)
• Grafts LLM onto specialized chemistry tools via action-queue API
• Successfully planned and executed multi-step syntheses
• Lesson for biology: The “LLM as orchestrator” pattern works when tools are well-defined and reliable

LangChain Bioinformatics Tools

Community-contributed LangChain tools for biology:

• BioPythonTools: Wraps BioPython functions (sequence manipulation, BLAST)
• AlphaFoldTool: Interfaces with AlphaFold servers
• PubmedTool: Literature search and summarization
• Status: Community-maintained; quality varies; good starting point for customization

Challenges and Limitations

Building biological agents is hard. Here are the key challenges:

1. Tool Reliability Variability

BLAST is rock-solid (30+ years of development). AlphaFold is highly reliable for monomeric proteins. But many bioinformatics tools:

• Have undocumented edge cases
• Fail silently on unusual inputs
• Return results that require expert interpretation

Mitigation: Implement result validation layers. For example, check that BLAST E-values are in expected ranges, that AlphaFold pLDDT scores are internally consistent, that variant coordinates match the reference genome.

2. Computational Cost

Running AlphaFold on a 2,000-amino-acid protein can take hours. scGPT inference on millions of cells requires significant GPU memory. Agents must:

• Queue long-running jobs
• Provide progress updates
• Offer approximate alternatives (ESMFold instead of AlphaFold for quick screening)

3. Hallucination Risk

LLMs hallucinate. In biology, hallucinations can be dangerous:

• Fabricated gene-disease associations
• Incorrect variant classifications
• Non-existent drug interactions

Mitigation:

• Ground all factual claims in tool outputs
• Implement fact-checking passes (query database again to verify)
• For clinical applications, require human review before any output reaches patients

4. Population Bias

Most genomic databases are >80% European ancestry. Agents trained or calibrated on these databases will perform worse for other populations:

• Polygenic risk scores have reduced accuracy in non-European populations
• Variant frequency estimates from gnomAD are skewed
• Reference genomes don’t capture population-specific variation

Mitigation:

• Always report ancestry context for population genetics claims
• Flag when analysis relies on Eurocentric databases
• Use diverse reference panels when available (All of Us, H3Africa)

5. The “Last Mile” Problem

Agents can generate hypotheses and predictions, but biological truth requires experimental validation. The gap between computational prediction and wet-lab confirmation remains wide:

• AlphaFold structures are predictions, not measurements
• Drug-target binding predictions require biochemical validation
• Gene expression predictions need qPCR or RNA-seq confirmation

Honest framing: Agents should present computational results as predictions requiring validation, not as established facts.

Getting Started: A Minimal Viable Agent

If you’re building your first biological agent, start small:

1. Pick one domain — variant interpretation, protein structure analysis, or literature review
2. Select 3-5 core tools — don’t try to integrate everything at once
3. Implement basic ReAct loop — thought, action, observation
4. Add confidence tracking — propagate uncertainty through reasoning
5. Test on known examples — use well-characterized variants/proteins with established answers
6. Iterate — add tools, improve prompts, handle edge cases

Example minimal variant interpretation agent:

• Tools: ClinVar lookup, AlphaFold structure prediction, PubMed search
• Input: Gene name + variant (e.g., “BRCA1 R1699Q”)
• Output: Pathogenicity assessment with evidence summary
• Validation: Compare against ClinVar classifications for known variants

Once this works reliably, expand to multi-omics integration, drug-target prediction, or experimental design.

Conclusion

Biological tool-use agents are not science fiction — they’re being built today. The architecture is clear: ReAct loops orchestrating domain-specific tools, with careful attention to confidence propagation, error handling, and provenance tracking. The tools exist: AlphaFold, ESM, BLAST, scGPT, and dozens of specialized databases and APIs.

But the hard work is in the details: handling partial results, managing computational costs, preventing hallucinations, and maintaining scientific rigor. The agents that succeed will be those that embrace uncertainty, document limitations, and keep humans in the loop for high-stakes decisions.

The next post in this series examines a specific high-value application: agents for drug discovery, where the agentic omics vision meets the multi-billion-dollar reality of pharmaceutical development.

Glossary

References

1. Bran, A. M., et al. “ChemCrow: Augmenting large-language models with chemistry tools.” Nature Machine Intelligence (2024). DOI: 10.1038/s42256-024-00823-x

2. Scientific Reports. “BioAgents: Bridging the gap in bioinformatics analysis with multi-agent systems.” Scientific Reports 15, Article number: 25919 (2025). DOI: 10.1038/s41598-025-25919-z

3. Frontiers in Artificial Intelligence. “AI, agentic models and lab automation for scientific discovery — the beginning of scAInce.” Front. Artif. Intell. (2025). DOI: 10.3389/frai.2025.1649155

4. LangChain. “LangGraph: Agent Orchestration Framework.” https://www.langchain.com/langgraph (2024-2025)

5. Jumper, J., et al. “Highly accurate protein structure prediction with AlphaFold.” Nature 596, 583-589 (2021). DOI: 10.1038/s41586-021-03819-2

6. Abramson, J., et al. “Accurate structure prediction of biomolecular interactions with AlphaFold 3.” Nature 630, 493-500 (2024). DOI: 10.1038/s41586-024-07487-w

7. Lin, Z., et al. “Evolutionary-scale prediction of atomic-level protein structure with a language model.” Science 379, 1123-1130 (2023). DOI: 10.1126/science.ade2574

8. Cui, H., et al. “scGPT: toward building a foundation model for single-cell multi-omics using generative AI.” Nature Methods 21, 1470-1481 (2024). DOI: 10.1038/s41592-024-02305-9

9. Zhou, Z., et al. “DNABERT-2: Efficient Foundation Model and Benchmark For Multi-Species Genome Understanding.” ICLR (2024). arXiv:2306.15006

10. Nguyen, E., et al. “Evo: A 7B-parameter model trained on 300B nucleotides spanning all domains of life.” Science (2024). DOI: 10.1126/science.adn1067

11. Briefings in Bioinformatics. “Streamline automated biomedical discoveries with agentic bioinformatics.” Brief. Bioinform. 26(5): bbaf505 (2025). DOI: 10.1093/bib/bbaf505

12. Nature. “Will self-driving ‘robot labs’ replace biologists? Paper sparks debate.” Nature (2026). DOI: 10.1038/d41586-026-00453-8

13. Wang, Y., et al. “The Virtual Lab: AI Agents Design New SARS-CoV-2 Nanobodies with Experimental Validation.” bioRxiv (2024). DOI: 10.1101/2024.11.11.623004

14. MDPI. “AlphaFold3: An Overview of Applications and Performance Insights.” Int. J. Mol. Sci. 26(8): 3671 (2025). DOI: 10.3390/ijms26083671

15. FEBS Open Bio. “An outlook on structural biology after AlphaFold: tools, limits and perspectives.” FEBS Open Bio (2024). DOI: 10.1002/2211-5463.13902